Date | Price Target | Rating | Analyst |
---|---|---|---|
4/21/2022 | $62.00 → $49.00 | Overweight → Neutral | Piper Sandler |
3/28/2022 | $80.00 → $54.00 | Outperform → Neutral | Wedbush |
2/24/2022 | $80.00 → $65.00 | Neutral | UBS |
2/4/2022 | $85.00 → $88.00 | Neutral → Outperform | Wedbush |
New innovation designed to help even more couples achieve quality sleep; Sleep Number now offers three smart beds under $2,000Today, Sleep Number Corporation (NASDAQ:SNBR), the sleep wellness technology leader, unveiled its new Sleep Number® c1 smart bed at only $999 (Queen). The brand's best value, the c1 offers the same signature adjustable firmness on either side and sleep technology features as Sleep Number's higher-end smart beds. For under $1,000, sleepers receive their ideal comfort and support; breathable technology that draws heat away from the body; and personalized digital sleep health insights to help improve sleep over time. And, because only Sleep Number® smart beds are designe
Shares of G-III Apparel Group, Ltd. (NASDAQ:GIII) fell sharply during Thursday's session after the company reported worse-than-expected quarterly sales results. G-III Apparel Group posted adjusted earnings of 13 cents per share, according to data from Benzinga Pro. The company's quarterly sales came in at $609.747 million, missing market estimates of $616.286 million. G-III Apparel Group shares dipped 13.4% to $27.12 on Thursday. Here are some other stocks moving in today’s mid-day session. Gainers Virax Biolabs Group Limited (NASDAQ:VRAX) shares jumped 139.4% to $2.5390. American Oncology Network, Inc. (NASDAQ:AONC) gained 102% to $4.52. American Oncology Network expanded
SC 13G/A - Sleep Number Corp (0000827187) (Subject)
SC 13G/A - Sleep Number Corp (0000827187) (Subject)
SC 13D/A - Sleep Number Corp (0000827187) (Subject)
NEW YORK, Nov. 28, 2023 /PRNewswire/ -- Worthington Steel Inc. (NYSE:WS) will be added to the S&P SmallCap 600 effective prior to the open of trading on Friday, December 1, replacing Sleep Number Corp. (NASD: SNBR) which will be removed from the S&P SmallCap 600 effective before the open of trading on Monday, December 4. S&P SmallCap 600 constituent Worthington Industries Inc. (NYSE:WOR) is spinning off Worthington Steel in a transaction expected to be completed on December 1. Post spin-off, the parent Worthington Industries will remain in the S&P SmallCap 600 and will change its name to Worthington Enterprises Inc. It will also have a GICS sector change to Consumer Discretionary. Sleep Numb
Announces Cooperation Agreement with Shareholder Stadium Capital Board to Form a Capital Allocation Committee, Comprised of New and Tenured Directors, to Provide Analysis and Recommendations to Board Sleep Number Corporation (NASDAQ:SNBR) today announced that it has appointed Stephen E. Macadam and Hilary A. Schneider to its Board of Directors (the "Board"), effective immediately, expanding the Board to twelve members. In conjunction with the appointments, Sleep Number entered into a cooperation agreement (the "Cooperation Agreement") with Stadium Capital Management, LLC (collectively with its affiliates, "Stadium Capital"), one of the company's shareholders. Steve Macadam is the Chai
Sleep Number joins the two organizations in their annual cancer awareness and early detection initiative and introduces a new resource, "The Defender Presented by Sleep Number" Today, wellness technology leader Sleep Number Corporation (NASDAQ:SNBR) announced they are the first "Official Crucial Catch Partner of the NFL," joining forces with the NFL and the American Cancer Society (ACS) in the fight against cancer. Crucial Catch was started by the NFL in 2009 to empower fans to take their health into their own hands through cancer screening, education and risk detection. To date, the initiative has raised over $27 million for ACS through sales of Crucial Catch branded merchandise, NFL Auc
Generated adjusted EBITDA of $28 million for the second quarter Delivered gross margin rate of 59.1% for the second quarter, up 150 basis points versus last year and ahead of expectations Reduced operating expenses by $19 million year-over-year for the quarter and $44 million year-to-date (both periods before restructuring costs) Year-to-date free cash flow increased $21 million compared with the same period last year Reiterate full-year 2024 adjusted EBITDA outlook of $125 million to $145 million Sleep Number Corporation (NASDAQ:SNBR) today reported results for the quarter ended June 29, 2024. "The implementation of our transformative initiatives is improving gross margin
Sleep Number Corporation (NASDAQ:SNBR) will release its second quarter results through June 29, 2024, after market close on Wednesday, July 31, 2024. Management will host its regularly scheduled conference call to discuss the company's results at 5 p.m. EDT (4 p.m. CDT; 2 p.m. PDT). To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days. About Sleep Number Corporation Sleep Number is a sleep wellness technology leader. Our life-changing innovations revolutionized the commoditized sleep industry and awakened consumers to the possibility of proven quality
Net sales of $470 million; adjusted EBITDA of $37 million slightly ahead of expectations Reduced operating expenses by $24 million year-over-year (before restructuring costs) and remain on track to deliver $40 million to $45 million of operating expense reductions for the year Free cash flow increased $21 million compared with the prior year's first quarter Reiterate full-year 2024 adjusted EBITDA outlook of $125 million to $145 million Sleep Number Corporation (NASDAQ:SNBR) today reported results for the quarter ended March 30, 2024. "Our actions to increase operating model efficiencies drove first quarter adjusted EBITDA and gross margin rate ahead of our expectations. We a
4 - Sleep Number Corp (0000827187) (Issuer)
4 - Sleep Number Corp (0000827187) (Issuer)
4 - Sleep Number Corp (0000827187) (Issuer)
4 - Sleep Number Corp (0000827187) (Issuer)
MedtechWOMEN is proud to announce Deborah Kilpatrick, PhD, Executive Chair and former CEO of Evidation Health and co-founder of MedtechWOMEN, as the recipient of the 2024 Ferolyn Powell Award. The award, named in honor of medtech pioneer Ferolyn Powell, celebrates leaders in the medical technology field who exemplify excellence, innovation, and a commitment to mentoring the next generation of leaders—values Ferolyn championed throughout her career. Kilpatrick accepted the award today during the annual MedtechVISION conference taking place at the Rosewood Sand Hill in Menlo Park, Calif. Amy Belt Raimundo, co-founder of MedtechWOMEN, reflected on the significance of this honor for Kilpatri
Generated adjusted EBITDA of $28 million for the second quarter Delivered gross margin rate of 59.1% for the second quarter, up 150 basis points versus last year and ahead of expectations Reduced operating expenses by $19 million year-over-year for the quarter and $44 million year-to-date (both periods before restructuring costs) Year-to-date free cash flow increased $21 million compared with the same period last year Reiterate full-year 2024 adjusted EBITDA outlook of $125 million to $145 million Sleep Number Corporation (NASDAQ:SNBR) today reported results for the quarter ended June 29, 2024. "The implementation of our transformative initiatives is improving gross margin
Sleep Number Corporation (NASDAQ:SNBR) will release its second quarter results through June 29, 2024, after market close on Wednesday, July 31, 2024. Management will host its regularly scheduled conference call to discuss the company's results at 5 p.m. EDT (4 p.m. CDT; 2 p.m. PDT). To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days. About Sleep Number Corporation Sleep Number is a sleep wellness technology leader. Our life-changing innovations revolutionized the commoditized sleep industry and awakened consumers to the possibility of proven quality
Piper Sandler downgraded Sleep Number from Overweight to Neutral and set a new price target of $49.00 from $62.00 previously
Wedbush downgraded Sleep Number from Outperform to Neutral and set a new price target of $54.00 from $80.00 previously
UBS reiterated coverage of Sleep Number with a rating of Neutral and set a new price target of $65.00 from $80.00 previously
10-Q - Sleep Number Corp (0000827187) (Filer)
8-K - Sleep Number Corp (0000827187) (Filer)
8-K - Sleep Number Corp (0000827187) (Filer)